Amongst the commonly used antibody-based techniques, immunoprecipitation (IP) is notoriously known for being tricky to perform. To help you carry out a successful IP, we'll talk about its principles and factors to consider in order for you to obtain quality results.
Guang Shi, a recent PhD graduate from the University of Toronto, has extensive experience working with IP and will be introducing principles and bench tips for this commonly used technique.
Read on to learn more about IP and how you can apply it in your work!
IP is a technique that is based on the principle of antibody-antigen interaction to enrich or isolate a protein from biological samples to study its identity, structure, expression and post-translational modifications. Variations of IP are used to study the interaction between the target protein (known as a bait) with other proteins (via Co-IP) or nucleic acids (via Chromatin IP or RNA-IP).
IP relies on the specific affinity between an antibody and its target protein. In an IP experiment, the antibody is incubated with lysates that contain the target protein. The antibody-protein complex formed during the incubation is then captured by antibody-binding proteins (such as Protein A or Protein B) that attached to agarose or magnetic beads. The target protein can then be eluted from the beads for further analysis.
Co-IP is basically performed in the same manner as IP. The only difference is that the bait protein isolated by the antibody in a co-IP is used to co-precipitate its binding protein(s) (also known as the prey) from a lysate.
IP was originally developed as an alternation of column affinity chromatography to prepare small amount of protein samples for analysis by western blot, mass spectrometry and other assays. Researchers routinely use IP to isolate proteins with low abundance from tissue or cell samples for their detection and identification. Since proteins in IP experiments remain post-translationally modified, IP is a core technique in post-translational modification detection assays.
Co-IP, in particular, is a popular method to identify physiologically relevant protein interactions. Using a bait protein-specific antibody, proteins that bind to the bait protein can be captured indirectly and an array of downstream studies can be performed on the captured protein complex to identify new binding patterns of the bait protein for the study of its function in cellular processes.
IP is ideal for small-scale enrichment of proteins. It is fast and relatively easy in comparison to affinity chromatography which is time-consuming and involves cycles of bind and washing.
Compared to other techniques that detect protein-protein interactions, co-IP is relatively easy and is compatible with most methods of the downstream analysis, such as western blog and mass spectrometry. Co-IP is a powerful technique to identify protein interactions with physiological importance, since both bait and its prey proteins are in their native conformations during the whole procedure. Thus, co-IP is considered as the golden standard assay for protein-protein interaction.
Despite being a powerful technique for analyzing protein interactions, co-IP might not be able to capture low affinity and transient protein interactions. In addition, the protein-protein interaction detected by co-IP may be indirect, as a third protein might be sandwiched in between the bait and prey proteins. As a result, results from co-IP must be further validated by other assays.
Co-IP is also limited by the availability of antibodies that recognize the bait protein. In some cases, the antibody that recognizes the bait protein might bind to the interacting site between bait and prey proteins and interfere or disrupt the interaction. Lastly, co-IP can only verify protein interactions between suspected interaction partners, thus it is not suitable for high-throughput screening approach.
Preparing cell lysates is the first, and a key, step in IP. Having the right lysis buffer is critical for preparing high-quality samples for IP, especially when detecting protein-protein interactions by co-IP. In our lab, non-denaturing buffers containing NP-40 and Triton X-100 were routinely used for preparing cell lysate for IP and co-IP. Digitonin is another non-denaturing detergent that works very well for solubilizing and preserving membrane protein complexes.
Denaturing buffers, such as radio-immunoprecipitation assay (RIPA) buffer, are more stringent and used to extract proteins that are difficult to release. It works well for the precipitation of nuclear proteins and multi-span membrane proteins. However, denaturing buffers will destroy any protein interactions, thus are not suitable for co-IP.
IP samples should always be kept on ice and protease/phosphatase inhibitors added to the lysis buffer to prevent proteolysis and dephosphorylation. Cell lysates can be stored at -80 degrees Celsius for up to a week. For co-IP, however, as some proteins can lose their native structures during the freeze-thaw cycle, resulting in the disruption of protein-protein interactions, it is recommended to work with fresh lysates when performing a co-IP.
Cell lysates contain mixtures of proteins, lipids, carbohydrates and nucleic acids. The selected capture antibody or the protein beads could potentially bind to these molecules non-specifically, leading to false positive results and messy background on your blots. To reduce non-specific binding, cell lysates can be pre-cleared by incubating with protein beads and/or isotype control antibodies prior to IP. This step is optional but is recommended for co-IP, as pre-clearing helps to remove any molecules that might bind non-specifically to the capture antibody and/or protein beads during immunoprecipitation, therefore reducing non-specific binding and improving the signal-to-noise ratio.
In an IP experiment, a pair of primary antibodies is used to capture and detect the target protein. Capture and detection antibody should originate from different species (ie: rabbit capture antibody and mouse detection antibody) to avoid the interference from the heavy and light chains of the capture antibody in the detection step.
At the first step of IP (binding between the capture antibody and the target protein), the goal is to establish a stable antibody-protein complex. As polyclonal antibodies bind to multiple epitopes on the target protein, they form tighter antibody-protein complexes in comparison to monoclonal antibodies. This high retention rates between the polyclonal antibody with the target protein also means the target protein is less likely to be washed away during the washing steps. Thus, polyclonal antibodies, where possible, should be used as capture antibodies. Monoclonal antibodies recognize a single epitope on the target protein, thus are less ideal for quick capture of the target protein. However, they make good detection antibodies for IP as monoclonal antibodies have high specificity to their target proteins that result in lower background. In our lab, we routinely use a combination of a polyclonal capture antibody and a monoclonal detection antibody to maximize the capture efficiency and detection specificity. In addition, there are several online tools to help with your antibody selection.
Protein G and Protein A conjugated beads are the most common systems to capture antibody-protein complex in an IP. Protein G and Protein A both have high affinity to antibodies. However, each of the antibody binding protein has different affinity for antibodies of different host and isotypes. The usage of the antibody binding protein should be determined based on the capture antibody used (more on binding profiles of Protein A and Protein G can be found here). Generally speaking, Protein A beads are better suited for rabbit antibodies, while protein G beads have higher affinity to mouse antibodies.
Agarose and magnetic beads are two of the most common supports used in IP. Agarose beads are relatively cheap and have high antibody binding capacity thanks to their sponge-like structures. The downside of this sponge-like structures is that antibodies can get trapped in the pores and become difficult to wash off. Therefore, pre-clearing the cell lysate and extensive washing is required when using agarose beads to reduce background. Agarose beads also need a longer incubation (6 hours to overnight) with the antibody-protein complex as the sponge-like structure significantly reduces the diffusion rate. When working with agarose beads, it is recommended to remove the tips’ edge in order to prevent damaging the beads and the protein-protein complex attached.
Magnetic beads, on the other hand, are much smaller than agarose beads with smooth outer surfaces. As a result, magnetic beads have a relatively lower binding capacity than agarose beads, thus more beads may be required for a given volume of sample. However, magnetic beads are easy to work with (no centrifugations between each wash), requires less washing (no “hidden surface” to trap antibodies) and the incubation time is much shorter (2-4 hours) due to a higher diffusion rate. All these features can minimize the potential damage to the captured protein complexes, making magnetic beads a good choice for IP, especially for co-IP.
During the final elution, the capture antibody you used in the IP will be pulled down along with the target protein. Antibodies usually consist of heave-chains (~50kDa) and light-chains (~25kDa). A eestern blot may detect the capture antibody in the eluent if the detection antibody is from the same species as the capture antibody. If the target protein runs around 50kDa or 25kDa, its signal will be masked by the antibody band. A simple solution to this problem is use capture and detection antibody that originate from different species as suggested in section 3. However, it might not be easy to find a good capture/detection antibody pair for a given protein.
If antibodies from same species have to be used, you can crosslink the capture antibody with protein beads and use this antibody-bead conjugate to precipitate your target protein. The crosslinked antibody will not elute with the target protein and thus will not interfere with the subsequent analysis. However, crosslinking capture antibody with protein beads might affect its binding capacity to the target protein. If this is the case, a gradient of Glycine (up to 1M) can be used to release the target protein from the conjugated antibody to prevent the interference from antibody chains.
Do you have any suggestions on how to perform a successful IP or co-IP experiments? Do you have questions on a particular step in the protocol? Let me know in the comment section below.
Editor's note: If you're planning an IP or co-IP experiment, be sure to review published data on BenchSci to find out which antibody is the most suitable for your experimental context. Simply search for your protein of interest and filter for "immunoprecipitation" or "co-immunoprecipitation."